Vlad Coric - Sep 22, 2022 Form 3 Insider Report for Biohaven Ltd. (BHVN)

Role: Chief Executive Officer, Director
Signature: /s/ George Clark, Attorney-in-Fact
Stock symbol: BHVN
Transactions as of: Sep 22, 2022
Transactions value $: $0
Form type: 3
Date filed: 9/28/2022, 08:51 PM
Previous filing: Jan 7, 2022
Next filing: Oct 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BHVN	No Securities Owned						0	Sep 22, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 3 is being filed in connection with the Securities and Exchange Commission's declaration of effectiveness of the Registration Statement on Form 10 of Biohaven Ltd., which describes the planned distribution by Biohaven Pharmaceutical Holding Company Ltd. of all of the common shares of Biohaven Ltd. Beginning on September 23, 2022, Issuer common shares traded on a "when-issued" basis on the New York Stock Exchange under the symbol "BHVN WI" and under "Biohaven Ltd." When-issued trading of SpinCo common shares will continue until the distribution occurs. SpinCo common shares are expected to begin "regular-way" trading on the NYSE under the symbol "BHVN" on the first trading day following the distribution date.